

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | diterpenoid biosynthetic process (GO:0016102) | 9.78923034 |
| 2 | axoneme assembly (GO:0035082) | 9.56766123 |
| 3 | left/right pattern formation (GO:0060972) | 8.42941568 |
| 4 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 7.48217053 |
| 5 | vitamin transmembrane transport (GO:0035461) | 7.44808094 |
| 6 | terpenoid biosynthetic process (GO:0016114) | 7.01162937 |
| 7 | one-carbon compound transport (GO:0019755) | 6.48302304 |
| 8 | regulation of cilium movement (GO:0003352) | 6.45307932 |
| 9 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 6.40218479 |
| 10 | microtubule bundle formation (GO:0001578) | 5.91506045 |
| 11 | intraciliary transport (GO:0042073) | 5.71016085 |
| 12 | left/right axis specification (GO:0070986) | 5.65689291 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.53826836 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 5.53826836 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.51549933 |
| 16 | lung epithelium development (GO:0060428) | 5.49984846 |
| 17 | ventricular system development (GO:0021591) | 5.39517342 |
| 18 | tolerance induction (GO:0002507) | 5.36430243 |
| 19 | cilium organization (GO:0044782) | 5.31112884 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.22869393 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 5.22869393 |
| 22 | cilium assembly (GO:0042384) | 5.16664088 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 5.04807747 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.99728481 |
| 25 | protein carboxylation (GO:0018214) | 4.99728481 |
| 26 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.98603581 |
| 27 | negative regulation of protein activation cascade (GO:2000258) | 4.95454653 |
| 28 | * retinoic acid metabolic process (GO:0042573) | 4.81541830 |
| 29 | centriole assembly (GO:0098534) | 4.80953666 |
| 30 | * ethanol oxidation (GO:0006069) | 4.80403358 |
| 31 | establishment of apical/basal cell polarity (GO:0035089) | 4.76459607 |
| 32 | bile acid biosynthetic process (GO:0006699) | 4.76277339 |
| 33 | negative regulation of complement activation (GO:0045916) | 4.73038219 |
| 34 | glomerular epithelial cell development (GO:0072310) | 4.71306934 |
| 35 | tryptophan catabolic process (GO:0006569) | 4.71045098 |
| 36 | indole-containing compound catabolic process (GO:0042436) | 4.71045098 |
| 37 | indolalkylamine catabolic process (GO:0046218) | 4.71045098 |
| 38 | kynurenine metabolic process (GO:0070189) | 4.68120065 |
| 39 | regulation of protein activation cascade (GO:2000257) | 4.67751377 |
| 40 | protein localization to cilium (GO:0061512) | 4.60779984 |
| 41 | regulation of germinal center formation (GO:0002634) | 4.60578111 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 4.60436688 |
| 43 | progesterone metabolic process (GO:0042448) | 4.58477855 |
| 44 | negative regulation of B cell mediated immunity (GO:0002713) | 4.58134260 |
| 45 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.58134260 |
| 46 | response to xenobiotic stimulus (GO:0009410) | 4.52285932 |
| 47 | regulation of complement activation (GO:0030449) | 4.49313479 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.47602145 |
| 49 | renal absorption (GO:0070293) | 4.41336222 |
| 50 | establishment of tissue polarity (GO:0007164) | 4.39497758 |
| 51 | establishment of planar polarity (GO:0001736) | 4.39497758 |
| 52 | xenobiotic catabolic process (GO:0042178) | 4.37288971 |
| 53 | cysteine metabolic process (GO:0006534) | 4.37191022 |
| 54 | sperm capacitation (GO:0048240) | 4.37132601 |
| 55 | tryptophan metabolic process (GO:0006568) | 4.37102036 |
| 56 | positive regulation of tolerance induction (GO:0002645) | 4.36773583 |
| 57 | O-glycan processing (GO:0016266) | 4.35465728 |
| 58 | L-ascorbic acid metabolic process (GO:0019852) | 4.34696994 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 4.32450519 |
| 60 | negative regulation of fibrinolysis (GO:0051918) | 4.30366429 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.29476197 |
| 62 | polyketide metabolic process (GO:0030638) | 4.27517914 |
| 63 | doxorubicin metabolic process (GO:0044598) | 4.27517914 |
| 64 | daunorubicin metabolic process (GO:0044597) | 4.27517914 |
| 65 | glyoxylate metabolic process (GO:0046487) | 4.24692923 |
| 66 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.21194210 |
| 67 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.18383865 |
| 68 | establishment of monopolar cell polarity (GO:0061162) | 4.18383865 |
| 69 | regulation of fibrinolysis (GO:0051917) | 4.15926818 |
| 70 | cellular component assembly involved in morphogenesis (GO:0010927) | 4.12127925 |
| 71 | cellular glucuronidation (GO:0052695) | 4.06328582 |
| 72 | fibrinolysis (GO:0042730) | 4.04079021 |
| 73 | glucuronate metabolic process (GO:0019585) | 4.03807625 |
| 74 | uronic acid metabolic process (GO:0006063) | 4.03807625 |
| 75 | valine metabolic process (GO:0006573) | 4.01200301 |
| 76 | complement activation, alternative pathway (GO:0006957) | 3.99185446 |
| 77 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.97820072 |
| 78 | multicellular organismal water homeostasis (GO:0050891) | 3.96650333 |
| 79 | microtubule-based movement (GO:0007018) | 3.96023675 |
| 80 | reverse cholesterol transport (GO:0043691) | 3.94074096 |
| 81 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.88878297 |
| 82 | desmosome organization (GO:0002934) | 3.88633915 |
| 83 | urea metabolic process (GO:0019627) | 3.88155617 |
| 84 | urea cycle (GO:0000050) | 3.88155617 |
| 85 | aldehyde catabolic process (GO:0046185) | 3.87459881 |
| 86 | bile acid metabolic process (GO:0008206) | 3.87065686 |
| 87 | lateral sprouting from an epithelium (GO:0060601) | 3.86855164 |
| 88 | * ethanol metabolic process (GO:0006067) | 3.85579364 |
| 89 | cell projection assembly (GO:0030031) | 3.83794738 |
| 90 | cilium morphogenesis (GO:0060271) | 3.79717520 |
| 91 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.79050292 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.78350503 |
| 93 | reactive oxygen species biosynthetic process (GO:1903409) | 3.78327942 |
| 94 | linoleic acid metabolic process (GO:0043651) | 3.75762453 |
| 95 | retinal metabolic process (GO:0042574) | 3.74836646 |
| 96 | carnitine metabolic process (GO:0009437) | 3.72833137 |
| 97 | regulation of microtubule-based movement (GO:0060632) | 3.72740263 |
| 98 | water homeostasis (GO:0030104) | 3.71156353 |
| 99 | epoxygenase P450 pathway (GO:0019373) | 3.70890460 |
| 100 | phospholipid efflux (GO:0033700) | 3.70226922 |
| 101 | macromolecular complex remodeling (GO:0034367) | 3.66831301 |
| 102 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66831301 |
| 103 | protein-lipid complex remodeling (GO:0034368) | 3.66831301 |
| 104 | glutathione derivative metabolic process (GO:1901685) | 3.63969481 |
| 105 | glutathione derivative biosynthetic process (GO:1901687) | 3.63969481 |
| 106 | acute-phase response (GO:0006953) | 3.61493580 |
| 107 | * primary alcohol metabolic process (GO:0034308) | 3.60035170 |
| 108 | serine family amino acid catabolic process (GO:0009071) | 3.59757098 |
| 109 | extracellular fibril organization (GO:0043206) | 3.58802733 |
| 110 | response to nitrosative stress (GO:0051409) | 3.58139602 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.57067970 |
| 112 | alpha-amino acid catabolic process (GO:1901606) | 3.54921398 |
| 113 | aromatic amino acid family metabolic process (GO:0009072) | 3.54572204 |
| 114 | benzene-containing compound metabolic process (GO:0042537) | 3.54507521 |
| 115 | cellular aldehyde metabolic process (GO:0006081) | 3.53591772 |
| 116 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.51662878 |
| 117 | oligosaccharide biosynthetic process (GO:0009312) | 3.51382566 |
| 118 | regulation of cholesterol esterification (GO:0010872) | 3.51371327 |
| 119 | regulation of triglyceride catabolic process (GO:0010896) | 3.50684154 |
| 120 | regulation of female gonad development (GO:2000194) | 3.49863134 |
| 121 | tyrosine metabolic process (GO:0006570) | 3.49294821 |
| 122 | coenzyme catabolic process (GO:0009109) | 3.48944601 |
| 123 | * primary alcohol catabolic process (GO:0034310) | 3.48872103 |
| 124 | nitrogen cycle metabolic process (GO:0071941) | 3.47350693 |
| 125 | homocysteine metabolic process (GO:0050667) | 3.45893238 |
| 126 | cytoplasmic microtubule organization (GO:0031122) | 3.45489725 |
| 127 | negative regulation of humoral immune response (GO:0002921) | 3.44609825 |
| 128 | negative regulation of sterol transport (GO:0032372) | 3.43893301 |
| 129 | negative regulation of cholesterol transport (GO:0032375) | 3.43893301 |
| 130 | regulation of cholesterol homeostasis (GO:2000188) | 3.41656292 |
| 131 | ear development (GO:0043583) | 3.41619885 |
| 132 | exogenous drug catabolic process (GO:0042738) | 3.40550495 |
| 133 | triglyceride homeostasis (GO:0070328) | 3.38409073 |
| 134 | acylglycerol homeostasis (GO:0055090) | 3.38409073 |
| 135 | regulation of phospholipase A2 activity (GO:0032429) | 3.38251415 |
| 136 | regulation of bile acid biosynthetic process (GO:0070857) | 3.37535877 |
| 137 | cellular amino acid catabolic process (GO:0009063) | 3.36618079 |
| 138 | antibacterial humoral response (GO:0019731) | 3.34297265 |
| 139 | regulation of interleukin-5 production (GO:0032674) | 3.34201325 |
| 140 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.34037194 |
| 141 | imidazole-containing compound metabolic process (GO:0052803) | 3.33340087 |
| 142 | regulation of tolerance induction (GO:0002643) | 3.32841257 |
| 143 | amine catabolic process (GO:0009310) | 3.29543108 |
| 144 | cellular biogenic amine catabolic process (GO:0042402) | 3.29543108 |
| 145 | positive regulation of blood coagulation (GO:0030194) | 3.29289520 |
| 146 | positive regulation of hemostasis (GO:1900048) | 3.29289520 |
| 147 | positive regulation of coagulation (GO:0050820) | 3.28258936 |
| 148 | acute inflammatory response (GO:0002526) | 3.25512764 |
| 149 | * retinol metabolic process (GO:0042572) | 3.24168322 |
| 150 | bile acid and bile salt transport (GO:0015721) | 3.24159400 |
| 151 | lysine catabolic process (GO:0006554) | 3.22433796 |
| 152 | lysine metabolic process (GO:0006553) | 3.22433796 |
| 153 | excretion (GO:0007588) | 3.21545472 |
| 154 | regulation of cholesterol metabolic process (GO:0090181) | 3.19315419 |
| 155 | fibril organization (GO:0097435) | 3.19117600 |
| 156 | flavonoid metabolic process (GO:0009812) | 3.18758627 |
| 157 | cholesterol efflux (GO:0033344) | 3.18111557 |
| 158 | glycine metabolic process (GO:0006544) | 3.17290703 |
| 159 | antimicrobial humoral response (GO:0019730) | 3.15809442 |
| 160 | complement activation, classical pathway (GO:0006958) | 3.15615046 |
| 161 | complement activation (GO:0006956) | 3.15590463 |
| 162 | microtubule depolymerization (GO:0007019) | 3.10909456 |
| 163 | apical protein localization (GO:0045176) | 3.09264869 |
| 164 | protein O-linked glycosylation (GO:0006493) | 3.05048955 |
| 165 | positive regulation of smoothened signaling pathway (GO:0045880) | 3.04303630 |
| 166 | glutathione metabolic process (GO:0006749) | 3.01874373 |
| 167 | C21-steroid hormone metabolic process (GO:0008207) | 2.99061727 |
| 168 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96596547 |
| 169 | polyol transport (GO:0015791) | 2.96456455 |
| 170 | microtubule polymerization or depolymerization (GO:0031109) | 2.95579551 |
| 171 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.92963339 |
| 172 | hydrogen peroxide catabolic process (GO:0042744) | 2.87442808 |
| 173 | negative regulation of inclusion body assembly (GO:0090084) | 2.86182394 |
| 174 | regulation of interleukin-13 production (GO:0032656) | 2.85869807 |
| 175 | hydrogen peroxide metabolic process (GO:0042743) | 2.84340889 |
| 176 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.83063544 |
| 177 | glutathione biosynthetic process (GO:0006750) | 2.80614110 |
| 178 | innate immune response in mucosa (GO:0002227) | 2.71573817 |
| 179 | hypotonic response (GO:0006971) | 2.69243137 |
| 180 | sodium ion homeostasis (GO:0055078) | 2.67057044 |
| 181 | drug catabolic process (GO:0042737) | 2.65874308 |
| 182 | centriole replication (GO:0007099) | 2.63564247 |
| 183 | sialylation (GO:0097503) | 2.61346749 |
| 184 | axonemal dynein complex assembly (GO:0070286) | 19.6415218 |
| 185 | cilium or flagellum-dependent cell motility (GO:0001539) | 15.5565966 |
| 186 | cilium movement (GO:0003341) | 13.8638082 |
| 187 | motile cilium assembly (GO:0044458) | 13.5278368 |
| 188 | epithelial cilium movement (GO:0003351) | 12.4610904 |
| 189 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 12.3569319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.79332141 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.21582481 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.16956835 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.60189137 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.11482150 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.90730122 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.51778898 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.45732286 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.42682408 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.20733141 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.18015156 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.99287318 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.88212661 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.87413997 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.84135111 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.74080806 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.34555207 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.23886148 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.23691152 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.14247452 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05999222 |
| 22 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.97618915 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.96489395 |
| 24 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.77162578 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74756436 |
| 26 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.72104833 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69516535 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.68814675 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68292201 |
| 30 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.67629506 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.66232107 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.65177424 |
| 33 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.62950528 |
| 34 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.62690915 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60954044 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54876121 |
| 37 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.54242722 |
| 38 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54131457 |
| 39 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54131457 |
| 40 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53187667 |
| 41 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53187667 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48079327 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47294819 |
| 44 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.47205347 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.42989730 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41495404 |
| 47 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40241836 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.39985533 |
| 49 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35563516 |
| 50 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.33286770 |
| 51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33204580 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.32062560 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31842798 |
| 54 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31771126 |
| 55 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30220272 |
| 56 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.30209250 |
| 57 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29116280 |
| 58 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27705273 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27563063 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.26712145 |
| 61 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.25447196 |
| 62 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25143000 |
| 63 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23672879 |
| 64 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.23396218 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21618456 |
| 66 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20177091 |
| 67 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19325899 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18778372 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17906665 |
| 70 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.17750498 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14045512 |
| 72 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.13517275 |
| 73 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.13177467 |
| 74 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.13172435 |
| 75 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11330118 |
| 76 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11282184 |
| 77 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.10326235 |
| 78 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.08196041 |
| 79 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07143590 |
| 80 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.06548429 |
| 81 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05692156 |
| 82 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.05603465 |
| 83 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.05411767 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04643523 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04314247 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03860280 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03560312 |
| 88 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.03551795 |
| 89 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03027442 |
| 90 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 1.02888757 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02624675 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01311647 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00614543 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00207535 |
| 95 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.98757308 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98147933 |
| 97 | P68_20966046_ChIP-Seq_HELA_Human | 0.97897666 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97894889 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97270746 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96933916 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96100155 |
| 102 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96057461 |
| 103 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95061976 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94130178 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94058630 |
| 106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93977037 |
| 107 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93339736 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92702282 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92557991 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92391773 |
| 111 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.92297970 |
| 112 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.92183900 |
| 113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91529718 |
| 114 | NFYA_21822215_ChIP-Seq_K562_Human | 0.91422990 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91142874 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90717912 |
| 117 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90712100 |
| 118 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90068120 |
| 119 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89664468 |
| 120 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88622901 |
| 121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88614784 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87280946 |
| 123 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85493933 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84982110 |
| 125 | NFYB_21822215_ChIP-Seq_K562_Human | 0.84405689 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83484648 |
| 127 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83338334 |
| 128 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83234339 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83098120 |
| 130 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.82781007 |
| 131 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.82260279 |
| 132 | P300_27268052_Chip-Seq_Bcells_Human | 0.82117018 |
| 133 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.81315365 |
| 134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79300292 |
| 135 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76269135 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74823631 |
| 137 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.74694304 |
| 138 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.74479873 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.73733246 |
| 140 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73349327 |
| 141 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73349327 |
| 142 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71116636 |
| 143 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.71020657 |
| 144 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.70664865 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70303766 |
| 146 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.67849922 |
| 147 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67278429 |
| 148 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.66501645 |
| 149 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65781664 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64081070 |
| 151 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.62867825 |
| 152 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.62430345 |
| 153 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.62415070 |
| 154 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.61687963 |
| 155 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.60475216 |
| 156 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60288060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.41346221 |
| 2 | MP0002653_abnormal_ependyma_morphology | 5.88197623 |
| 3 | MP0005360_urolithiasis | 4.84228469 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.75510396 |
| 5 | MP0005365_abnormal_bile_salt | 4.40204119 |
| 6 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.16063536 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 4.13995664 |
| 8 | MP0008789_abnormal_olfactory_epithelium | 3.67868716 |
| 9 | MP0001984_abnormal_olfaction | 3.42564527 |
| 10 | MP0003252_abnormal_bile_duct | 3.22047132 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.22009007 |
| 12 | MP0004133_heterotaxia | 3.12301015 |
| 13 | MP0000566_synostosis | 3.00956783 |
| 14 | MP0002277_abnormal_respiratory_mucosa | 2.92069781 |
| 15 | MP0002796_impaired_skin_barrier | 2.88421643 |
| 16 | MP0005083_abnormal_biliary_tract | 2.84344391 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.67108860 |
| 18 | MP0002254_reproductive_system_inflammat | 2.58708811 |
| 19 | MP0005499_abnormal_olfactory_system | 2.41327964 |
| 20 | MP0005394_taste/olfaction_phenotype | 2.41327964 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.39484179 |
| 22 | MP0003878_abnormal_ear_physiology | 2.23987140 |
| 23 | MP0005377_hearing/vestibular/ear_phenot | 2.23987140 |
| 24 | MP0005623_abnormal_meninges_morphology | 2.22255670 |
| 25 | MP0005275_abnormal_skin_tensile | 2.18676990 |
| 26 | MP0000678_abnormal_parathyroid_gland | 2.15401989 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.15190580 |
| 28 | MP0002060_abnormal_skin_morphology | 2.09306224 |
| 29 | * MP0004019_abnormal_vitamin_homeostasis | 2.02640942 |
| 30 | MP0002168_other_aberrant_phenotype | 1.99839226 |
| 31 | MP0009379_abnormal_foot_pigmentation | 1.91201516 |
| 32 | MP0001765_abnormal_ion_homeostasis | 1.90323175 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.78446234 |
| 34 | MP0001346_abnormal_lacrimal_gland | 1.77333585 |
| 35 | MP0003186_abnormal_redox_activity | 1.77292532 |
| 36 | MP0003195_calcinosis | 1.76305248 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.72166671 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.68192853 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.67431755 |
| 40 | MP0009840_abnormal_foam_cell | 1.66983362 |
| 41 | MP0005501_abnormal_skin_physiology | 1.66228282 |
| 42 | MP0000579_abnormal_nail_morphology | 1.65609689 |
| 43 | MP0010030_abnormal_orbit_morphology | 1.65271363 |
| 44 | MP0005332_abnormal_amino_acid | 1.61793462 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.53424017 |
| 46 | MP0008004_abnormal_stomach_pH | 1.51978941 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.51312024 |
| 48 | MP0000609_abnormal_liver_physiology | 1.51094758 |
| 49 | MP0002160_abnormal_reproductive_system | 1.50542900 |
| 50 | MP0005408_hypopigmentation | 1.45966864 |
| 51 | MP0003941_abnormal_skin_development | 1.44789525 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.42958997 |
| 53 | MP0003011_delayed_dark_adaptation | 1.41607531 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.41029326 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.39479554 |
| 56 | MP0005248_abnormal_Harderian_gland | 1.39217269 |
| 57 | MP0000647_abnormal_sebaceous_gland | 1.39123933 |
| 58 | MP0002132_abnormal_respiratory_system | 1.38117298 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.38002714 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.37410358 |
| 61 | MP0000467_abnormal_esophagus_morphology | 1.31199026 |
| 62 | MP0001216_abnormal_epidermal_layer | 1.31084424 |
| 63 | MP0002098_abnormal_vibrissa_morphology | 1.26853781 |
| 64 | MP0009053_abnormal_anal_canal | 1.26823122 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.26550018 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 1.25859207 |
| 67 | MP0005395_other_phenotype | 1.25096818 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.23995551 |
| 69 | MP0010771_integument_phenotype | 1.19937390 |
| 70 | MP0000383_abnormal_hair_follicle | 1.19702039 |
| 71 | MP0000858_altered_metastatic_potential | 1.19618262 |
| 72 | MP0004381_abnormal_hair_follicle | 1.19340722 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.16474632 |
| 74 | MP0002233_abnormal_nose_morphology | 1.13709688 |
| 75 | MP0003303_peritoneal_inflammation | 1.13072163 |
| 76 | MP0000537_abnormal_urethra_morphology | 1.11903706 |
| 77 | MP0004043_abnormal_pH_regulation | 1.11065404 |
| 78 | MP0010678_abnormal_skin_adnexa | 1.11045977 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 1.10860715 |
| 80 | MP0009643_abnormal_urine_homeostasis | 1.09681026 |
| 81 | MP0001243_abnormal_dermal_layer | 1.08610177 |
| 82 | MP0003950_abnormal_plasma_membrane | 1.08469408 |
| 83 | MP0009764_decreased_sensitivity_to | 1.07846338 |
| 84 | MP0006054_spinal_hemorrhage | 1.07199958 |
| 85 | MP0005451_abnormal_body_composition | 1.06580738 |
| 86 | MP0005023_abnormal_wound_healing | 1.05032678 |
| 87 | MP0004883_abnormal_blood_vessel | 1.00346110 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.99133858 |
| 89 | MP0004947_skin_inflammation | 0.98292619 |
| 90 | MP0000377_abnormal_hair_follicle | 0.98025209 |
| 91 | MP0005503_abnormal_tendon_morphology | 0.97701102 |
| 92 | MP0000427_abnormal_hair_cycle | 0.95570255 |
| 93 | MP0008872_abnormal_physiological_respon | 0.93282001 |
| 94 | MP0003136_yellow_coat_color | 0.93106883 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.92970690 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.89131561 |
| 97 | MP0003868_abnormal_feces_composition | 0.86711704 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86444841 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.82116490 |
| 100 | MP0005310_abnormal_salivary_gland | 0.80137105 |
| 101 | MP0000598_abnormal_liver_morphology | 0.79574420 |
| 102 | MP0001191_abnormal_skin_condition | 0.78694998 |
| 103 | MP0003724_increased_susceptibility_to | 0.77768003 |
| 104 | MP0003075_altered_response_to | 0.76331195 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.75572842 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.73932430 |
| 107 | MP0009697_abnormal_copulation | 0.73805047 |
| 108 | MP0001756_abnormal_urination | 0.73147106 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.72805064 |
| 110 | MP0002295_abnormal_pulmonary_circulatio | 0.72407546 |
| 111 | MP0004885_abnormal_endolymph | 0.71552919 |
| 112 | MP0009931_abnormal_skin_appearance | 0.70881291 |
| 113 | MP0001915_intracranial_hemorrhage | 0.70325933 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.70004235 |
| 115 | MP0003279_aneurysm | 0.69555550 |
| 116 | MP0001270_distended_abdomen | 0.68900983 |
| 117 | MP0001663_abnormal_digestive_system | 0.68853059 |
| 118 | MP0004272_abnormal_basement_membrane | 0.68772221 |
| 119 | MP0005220_abnormal_exocrine_pancreas | 0.67101178 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.65644993 |
| 121 | MP0001664_abnormal_digestion | 0.65270181 |
| 122 | * MP0009763_increased_sensitivity_to | 0.65073705 |
| 123 | MP0003866_abnormal_defecation | 0.64826142 |
| 124 | MP0005389_reproductive_system_phenotype | 0.64628172 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.64006200 |
| 126 | MP0000026_abnormal_inner_ear | 0.63473740 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.63318664 |
| 128 | MP0005165_increased_susceptibility_to | 0.63147096 |
| 129 | MP0000367_abnormal_coat/_hair | 0.59911911 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.59474856 |
| 131 | MP0003828_pulmonary_edema | 0.59267970 |
| 132 | MP0001340_abnormal_eyelid_morphology | 0.58969931 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.58521781 |
| 134 | MP0002282_abnormal_trachea_morphology | 0.57891260 |
| 135 | MP0003300_gastrointestinal_ulcer | 0.57762850 |
| 136 | MP0005387_immune_system_phenotype | 0.57680849 |
| 137 | MP0001790_abnormal_immune_system | 0.57680849 |
| 138 | MP0001929_abnormal_gametogenesis | 0.57474055 |
| 139 | MP0002249_abnormal_larynx_morphology | 0.56272304 |
| 140 | MP0002405_respiratory_system_inflammati | 0.56074012 |
| 141 | MP0001958_emphysema | 0.55205836 |
| 142 | MP0005164_abnormal_response_to | 0.54669728 |
| 143 | MP0003698_abnormal_male_reproductive | 0.54627551 |
| 144 | MP0001849_ear_inflammation | 0.54416888 |
| 145 | MP0002638_abnormal_pupillary_reflex | 0.54331932 |
| 146 | MP0001502_abnormal_circadian_rhythm | 0.53018934 |
| 147 | MP0002735_abnormal_chemical_nociception | 0.52684572 |
| 148 | MP0001764_abnormal_homeostasis | 0.52471329 |
| 149 | MP0003656_abnormal_erythrocyte_physiolo | 0.52252296 |
| 150 | MP0005376_homeostasis/metabolism_phenot | 0.51341454 |
| 151 | MP0000613_abnormal_salivary_gland | 0.49428360 |
| 152 | MP0003890_abnormal_embryonic-extraembry | 0.48986317 |
| 153 | MP0005409_darkened_coat_color | 0.47813375 |
| 154 | MP0003937_abnormal_limbs/digits/tail_de | 0.46813852 |
| 155 | MP0005388_respiratory_system_phenotype | 0.45787260 |
| 156 | MP0002133_abnormal_respiratory_system | 0.45787260 |
| 157 | MP0000477_abnormal_intestine_morphology | 0.42367663 |
| 158 | MP0002822_catalepsy | 0.42261735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic bronchitis (HP:0004469) | 8.50957216 |
| 2 | Bronchiectasis (HP:0002110) | 7.43055407 |
| 3 | Nasal polyposis (HP:0100582) | 6.74425894 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.76022336 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.72988291 |
| 6 | Abnormality of the nasal mucosa (HP:0000433) | 5.59426724 |
| 7 | Xanthomatosis (HP:0000991) | 5.31809447 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.30753941 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.07950736 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.54075996 |
| 11 | Bronchitis (HP:0012387) | 4.47869485 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 4.43345781 |
| 13 | Recurrent sinusitis (HP:0011108) | 4.25719215 |
| 14 | Infertility (HP:0000789) | 4.18075593 |
| 15 | Hyperactive renin-angiotensin system (HP:0000841) | 4.13250295 |
| 16 | Chronic sinusitis (HP:0011109) | 4.07294853 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.02025596 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01870996 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.98003348 |
| 20 | Complement deficiency (HP:0004431) | 3.97407639 |
| 21 | Male infertility (HP:0003251) | 3.94527226 |
| 22 | Distal lower limb muscle weakness (HP:0009053) | 3.89511462 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.86327476 |
| 24 | Recurrent otitis media (HP:0000403) | 3.80852012 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.55718719 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.54746492 |
| 27 | Epidermoid cyst (HP:0200040) | 3.47183161 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.42440599 |
| 29 | Occipital encephalocele (HP:0002085) | 3.41520700 |
| 30 | Myocardial infarction (HP:0001658) | 3.38846927 |
| 31 | Pancreatic fibrosis (HP:0100732) | 3.33937860 |
| 32 | Abnormality of complement system (HP:0005339) | 3.31695169 |
| 33 | Onycholysis (HP:0001806) | 3.29281022 |
| 34 | Hyperglycinemia (HP:0002154) | 3.25968167 |
| 35 | True hermaphroditism (HP:0010459) | 3.25593285 |
| 36 | Chronic otitis media (HP:0000389) | 3.08474040 |
| 37 | Joint hemorrhage (HP:0005261) | 3.08266483 |
| 38 | Abnormal hemoglobin (HP:0011902) | 3.08222497 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.06323537 |
| 40 | Fat malabsorption (HP:0002630) | 3.03400635 |
| 41 | Ketosis (HP:0001946) | 2.93384917 |
| 42 | Hyperammonemia (HP:0001987) | 2.92240399 |
| 43 | Atelectasis (HP:0100750) | 2.90333636 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.89839318 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 2.88463093 |
| 46 | Abnormality of glycine metabolism (HP:0010895) | 2.81032552 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.81032552 |
| 48 | Cystic liver disease (HP:0006706) | 2.80364805 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79199237 |
| 50 | Alopecia of scalp (HP:0002293) | 2.78294615 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.74438378 |
| 52 | Pancreatic cysts (HP:0001737) | 2.71758695 |
| 53 | Vascular calcification (HP:0004934) | 2.71580511 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.70233033 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.70233033 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.70138923 |
| 57 | Plantar hyperkeratosis (HP:0007556) | 2.69901209 |
| 58 | Impaired platelet aggregation (HP:0003540) | 2.69714028 |
| 59 | Abnormal platelet function (HP:0011869) | 2.69714028 |
| 60 | Hyperglycinuria (HP:0003108) | 2.67521056 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.63800332 |
| 62 | Spastic diplegia (HP:0001264) | 2.63235263 |
| 63 | Abnormality of the intrinsic pathway (HP:0010989) | 2.57802555 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.56478687 |
| 65 | Hypercholesterolemia (HP:0003124) | 2.55697663 |
| 66 | Nephronophthisis (HP:0000090) | 2.55209608 |
| 67 | Gout (HP:0001997) | 2.53543829 |
| 68 | Hypokalemic alkalosis (HP:0001949) | 2.49743115 |
| 69 | Increased circulating renin level (HP:0000848) | 2.47053079 |
| 70 | Esophageal varix (HP:0002040) | 2.40913794 |
| 71 | Peritonitis (HP:0002586) | 2.39877061 |
| 72 | Postaxial foot polydactyly (HP:0001830) | 2.32489882 |
| 73 | Scanning speech (HP:0002168) | 2.30013873 |
| 74 | Chronic hepatic failure (HP:0100626) | 2.28112347 |
| 75 | Premature rupture of membranes (HP:0001788) | 2.26759610 |
| 76 | Protrusio acetabuli (HP:0003179) | 2.26742715 |
| 77 | Renal salt wasting (HP:0000127) | 2.25302621 |
| 78 | Ketoacidosis (HP:0001993) | 2.25024047 |
| 79 | Decreased circulating renin level (HP:0003351) | 2.24322610 |
| 80 | Atrophic scars (HP:0001075) | 2.23518258 |
| 81 | Palmoplantar hyperkeratosis (HP:0000972) | 2.23394256 |
| 82 | Steatorrhea (HP:0002570) | 2.23329410 |
| 83 | Hyperkalemia (HP:0002153) | 2.21447594 |
| 84 | Alkalosis (HP:0001948) | 2.20251741 |
| 85 | Amyloidosis (HP:0011034) | 2.20084399 |
| 86 | Chondrocalcinosis (HP:0000934) | 2.18285742 |
| 87 | Delayed CNS myelination (HP:0002188) | 2.17214815 |
| 88 | Abnormality of purine metabolism (HP:0004352) | 2.15027381 |
| 89 | Increased connective tissue (HP:0009025) | 2.13906076 |
| 90 | Tubulointerstitial nephritis (HP:0001970) | 2.11268686 |
| 91 | Abnormality of chloride homeostasis (HP:0011422) | 2.10201515 |
| 92 | Abnormality of nucleobase metabolism (HP:0010932) | 2.09339979 |
| 93 | Fragile nails (HP:0001808) | 2.07937150 |
| 94 | Tetany (HP:0001281) | 2.06445845 |
| 95 | Abnormality of the renal medulla (HP:0100957) | 2.06215499 |
| 96 | Mitral stenosis (HP:0001718) | 2.05192791 |
| 97 | Abnormality of Sharpey fibers (HP:0100685) | 2.03977101 |
| 98 | Skin nodule (HP:0200036) | 2.02614588 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.01804990 |
| 100 | Hyperbilirubinemia (HP:0002904) | 2.01318210 |
| 101 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00972022 |
| 102 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 12.1339165 |
| 103 | Abnormal respiratory epithelium morphology (HP:0012253) | 10.9389425 |
| 104 | Abnormal respiratory motile cilium morphology (HP:0005938) | 10.9389425 |
| 105 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.7885474 |
| 106 | Absent/shortened dynein arms (HP:0200106) | 10.6123555 |
| 107 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.6123555 |
| 108 | Abnormal ciliary motility (HP:0012262) | 10.4203849 |
| 109 | Rhinitis (HP:0012384) | 10.0656124 |
| 110 | Palmar hyperkeratosis (HP:0010765) | 1.99944129 |
| 111 | Hypoglycemic seizures (HP:0002173) | 1.99912172 |
| 112 | Large eyes (HP:0001090) | 1.99661525 |
| 113 | Acanthosis nigricans (HP:0000956) | 1.98438548 |
| 114 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97965176 |
| 115 | Abnormality of serum amino acid levels (HP:0003112) | 1.97075154 |
| 116 | Hyperaldosteronism (HP:0000859) | 1.96053977 |
| 117 | Renal cortical cysts (HP:0000803) | 1.93673089 |
| 118 | Congenital hepatic fibrosis (HP:0002612) | 1.92811405 |
| 119 | Bell-shaped thorax (HP:0001591) | 1.92305690 |
| 120 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.92226185 |
| 121 | Woolly hair (HP:0002224) | 1.91924635 |
| 122 | Male pseudohermaphroditism (HP:0000037) | 1.88973035 |
| 123 | Lip pit (HP:0100267) | 1.87651000 |
| 124 | Spontaneous abortion (HP:0005268) | 1.86696324 |
| 125 | Fragile skin (HP:0001030) | 1.86229725 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.86116680 |
| 127 | Anencephaly (HP:0002323) | 1.85609949 |
| 128 | Hyperglycemia (HP:0003074) | 1.83302238 |
| 129 | Neonatal onset (HP:0003623) | 1.81537245 |
| 130 | Metabolic acidosis (HP:0001942) | 1.81129055 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.80785298 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.80785298 |
| 133 | Glomerulosclerosis (HP:0000096) | 1.80498670 |
| 134 | Metabolic alkalosis (HP:0200114) | 1.79623620 |
| 135 | Hypotrichosis (HP:0001006) | 1.77376955 |
| 136 | Furrowed tongue (HP:0000221) | 1.77302116 |
| 137 | Medial flaring of the eyebrow (HP:0010747) | 1.77068217 |
| 138 | Rickets (HP:0002748) | 1.77024313 |
| 139 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.76655424 |
| 140 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76554730 |
| 141 | Bifid scrotum (HP:0000048) | 1.76242490 |
| 142 | Pancreatitis (HP:0001733) | 1.73051724 |
| 143 | Abnormal blistering of the skin (HP:0008066) | 1.72973342 |
| 144 | Nephropathy (HP:0000112) | 1.72942758 |
| 145 | Recurrent bronchitis (HP:0002837) | 1.70746670 |
| 146 | Absent frontal sinuses (HP:0002688) | 1.70509444 |
| 147 | Asplenia (HP:0001746) | 1.64033826 |
| 148 | Congenital primary aphakia (HP:0007707) | 1.63656765 |
| 149 | Gait imbalance (HP:0002141) | 1.61798166 |
| 150 | Tubular atrophy (HP:0000092) | 1.59922575 |
| 151 | Hyponatremia (HP:0002902) | 1.59437003 |
| 152 | Sclerocornea (HP:0000647) | 1.58669330 |
| 153 | Oculomotor apraxia (HP:0000657) | 1.50446140 |
| 154 | Postaxial hand polydactyly (HP:0001162) | 1.49478108 |
| 155 | Nephrogenic diabetes insipidus (HP:0009806) | 1.42042475 |
| 156 | Abnormality of permanent molar morphology (HP:0011071) | 1.40645094 |
| 157 | Abnormality of the dental root (HP:0006486) | 1.40645094 |
| 158 | Taurodontia (HP:0000679) | 1.40645094 |
| 159 | Median cleft lip (HP:0000161) | 1.37716074 |
| 160 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.33960632 |
| 161 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.33839868 |
| 162 | Abnormality of molar morphology (HP:0011070) | 1.29445122 |
| 163 | Abnormality of molar (HP:0011077) | 1.29445122 |
| 164 | Popliteal pterygium (HP:0009756) | 1.28149340 |
| 165 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.26994588 |
| 166 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.25951612 |
| 167 | Abnormality of the dental pulp (HP:0006479) | 1.25280980 |
| 168 | Abnormality of sodium homeostasis (HP:0010931) | 1.22161750 |
| 169 | Short thorax (HP:0010306) | 1.21290933 |
| 170 | Preaxial hand polydactyly (HP:0001177) | 1.21250753 |
| 171 | Glucose intolerance (HP:0000833) | 1.19435484 |
| 172 | Tubulointerstitial abnormality (HP:0001969) | 1.17476170 |
| 173 | Short femoral neck (HP:0100864) | 1.12390021 |
| 174 | Hand muscle atrophy (HP:0009130) | 1.11262764 |
| 175 | Decreased central vision (HP:0007663) | 1.09814242 |
| 176 | Spinal muscular atrophy (HP:0007269) | 1.09512207 |
| 177 | Stage 5 chronic kidney disease (HP:0003774) | 1.09342250 |
| 178 | Vaginal atresia (HP:0000148) | 1.07362903 |
| 179 | Genital tract atresia (HP:0001827) | 1.07060961 |
| 180 | Obstructive sleep apnea (HP:0002870) | 1.06937901 |
| 181 | Tubulointerstitial fibrosis (HP:0005576) | 1.05691679 |
| 182 | Fetal akinesia sequence (HP:0001989) | 1.05500584 |
| 183 | Recurrent corneal erosions (HP:0000495) | 1.05466868 |
| 184 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.05134467 |
| 185 | Abnormality of the frontal sinuses (HP:0002687) | 1.04512223 |
| 186 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.03294754 |
| 187 | Poor coordination (HP:0002370) | 1.02629376 |
| 188 | Adrenal overactivity (HP:0002717) | 1.01061718 |
| 189 | Carpal bone hypoplasia (HP:0001498) | 1.01005351 |
| 190 | Flat acetabular roof (HP:0003180) | 0.99786241 |
| 191 | Limb-girdle muscle atrophy (HP:0003797) | 0.99754937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 5.25323327 |
| 2 | MST4 | 3.96852814 |
| 3 | SIK3 | 3.73765404 |
| 4 | MST1R | 3.46248360 |
| 5 | ERN1 | 3.41184946 |
| 6 | SMG1 | 2.60000588 |
| 7 | FER | 2.50469673 |
| 8 | BCKDK | 2.45469747 |
| 9 | LATS1 | 2.32875934 |
| 10 | MAP3K3 | 2.29655198 |
| 11 | NME1 | 2.24726309 |
| 12 | TTN | 2.10165119 |
| 13 | SIK2 | 2.02399573 |
| 14 | STK24 | 2.00849028 |
| 15 | LRRK2 | 2.00634337 |
| 16 | TRPM7 | 1.89882198 |
| 17 | EPHB2 | 1.78041285 |
| 18 | SGK3 | 1.77112157 |
| 19 | TTK | 1.73099883 |
| 20 | RPS6KB2 | 1.69254452 |
| 21 | ERBB4 | 1.65341294 |
| 22 | FGFR4 | 1.63957893 |
| 23 | STK10 | 1.63731568 |
| 24 | MAPKAPK3 | 1.55437757 |
| 25 | INSRR | 1.54990158 |
| 26 | PBK | 1.54672227 |
| 27 | TRIB3 | 1.53515184 |
| 28 | STK38L | 1.52424007 |
| 29 | TYRO3 | 1.47044660 |
| 30 | ERBB3 | 1.45667389 |
| 31 | NEK9 | 1.43502270 |
| 32 | CDK6 | 1.40569903 |
| 33 | MET | 1.38582132 |
| 34 | SGK2 | 1.38135839 |
| 35 | NEK6 | 1.37281241 |
| 36 | PKN2 | 1.33404108 |
| 37 | MAP3K2 | 1.29681885 |
| 38 | PTK2B | 1.29284090 |
| 39 | TLK1 | 1.28551179 |
| 40 | EPHA2 | 1.28370944 |
| 41 | PDK2 | 1.24884866 |
| 42 | FRK | 1.23951805 |
| 43 | MAP2K3 | 1.21966708 |
| 44 | PIK3CG | 1.21801448 |
| 45 | PTK6 | 1.21131742 |
| 46 | BCR | 1.15549418 |
| 47 | TNK2 | 1.15471817 |
| 48 | ADRBK2 | 1.13176692 |
| 49 | DDR2 | 1.07493291 |
| 50 | SGK223 | 1.06706492 |
| 51 | SGK494 | 1.06706492 |
| 52 | PTK2 | 1.04993699 |
| 53 | ICK | 1.03961728 |
| 54 | MARK3 | 1.03876791 |
| 55 | TAOK1 | 1.01317522 |
| 56 | GRK6 | 1.00820974 |
| 57 | BRSK2 | 0.99707653 |
| 58 | EEF2K | 0.98743811 |
| 59 | TBK1 | 0.98597111 |
| 60 | MAP2K1 | 0.93020362 |
| 61 | LATS2 | 0.92439376 |
| 62 | MAP3K7 | 0.92417568 |
| 63 | PAK3 | 0.89759030 |
| 64 | TAOK2 | 0.89101249 |
| 65 | MAP2K2 | 0.87998466 |
| 66 | MAP3K12 | 0.86575523 |
| 67 | FGFR2 | 0.83439059 |
| 68 | PRKCI | 0.83145772 |
| 69 | PNCK | 0.77779926 |
| 70 | RIPK4 | 0.77376162 |
| 71 | PDK3 | 0.76659710 |
| 72 | PDK4 | 0.76659710 |
| 73 | TGFBR2 | 0.72581367 |
| 74 | TYK2 | 0.71683940 |
| 75 | EPHA3 | 0.70894238 |
| 76 | DAPK2 | 0.68866239 |
| 77 | CAMKK1 | 0.62237532 |
| 78 | ERBB2 | 0.61137958 |
| 79 | FLT3 | 0.60561679 |
| 80 | TESK1 | 0.59649164 |
| 81 | EPHB1 | 0.59327252 |
| 82 | DYRK1B | 0.58496820 |
| 83 | PRKCD | 0.58123996 |
| 84 | MAP3K11 | 0.57038936 |
| 85 | ADRBK1 | 0.56559116 |
| 86 | MAP2K4 | 0.55987838 |
| 87 | PRKD1 | 0.55201076 |
| 88 | STK3 | 0.52005388 |
| 89 | RPS6KA4 | 0.51467941 |
| 90 | ABL2 | 0.49849596 |
| 91 | MAPK15 | 0.49652705 |
| 92 | BMX | 0.49478068 |
| 93 | TAOK3 | 0.47452430 |
| 94 | MUSK | 0.45842108 |
| 95 | JAK1 | 0.45111503 |
| 96 | IRAK3 | 0.43684123 |
| 97 | STK16 | 0.43601568 |
| 98 | RIPK1 | 0.43090268 |
| 99 | PRKCQ | 0.42670714 |
| 100 | MAPK11 | 0.41834711 |
| 101 | PDGFRA | 0.41820285 |
| 102 | AURKA | 0.41782753 |
| 103 | IRAK1 | 0.41634084 |
| 104 | MAP3K1 | 0.40623373 |
| 105 | HIPK2 | 0.40555062 |
| 106 | ZAP70 | 0.40261877 |
| 107 | CAMK2G | 0.39242212 |
| 108 | FGFR1 | 0.38677843 |
| 109 | SGK1 | 0.38030637 |
| 110 | LMTK2 | 0.37199322 |
| 111 | PRKG2 | 0.36263035 |
| 112 | PAK2 | 0.36079474 |
| 113 | PDGFRB | 0.35964390 |
| 114 | JAK2 | 0.35310024 |
| 115 | NLK | 0.35143167 |
| 116 | LIMK1 | 0.33709446 |
| 117 | CSK | 0.33226927 |
| 118 | BMPR2 | 0.32180209 |
| 119 | TGFBR1 | 0.32034064 |
| 120 | MAP3K4 | 0.31062775 |
| 121 | IGF1R | 0.30732881 |
| 122 | MARK2 | 0.30161279 |
| 123 | PRKAA2 | 0.29829936 |
| 124 | MAP4K2 | 0.29670884 |
| 125 | ABL1 | 0.29565109 |
| 126 | MYLK | 0.28734931 |
| 127 | MAP3K14 | 0.27741466 |
| 128 | MAP2K6 | 0.27540994 |
| 129 | MAPKAPK5 | 0.27390936 |
| 130 | GRK1 | 0.27290930 |
| 131 | PDPK1 | 0.27085443 |
| 132 | PRKCA | 0.26889403 |
| 133 | MAP3K8 | 0.26153625 |
| 134 | NME2 | 0.25664168 |
| 135 | PIK3CA | 0.25076270 |
| 136 | SRC | 0.24660340 |
| 137 | FYN | 0.24005223 |
| 138 | STK38 | 0.24005053 |
| 139 | PRKACA | 0.23728892 |
| 140 | STK39 | 0.23607424 |
| 141 | OXSR1 | 0.23399005 |
| 142 | FGFR3 | 0.23255014 |
| 143 | STK4 | 0.23106738 |
| 144 | MAP3K6 | 0.22769596 |
| 145 | MAP2K7 | 0.21771445 |
| 146 | MATK | 0.20709625 |
| 147 | MAPK13 | 0.19565909 |
| 148 | IKBKE | 0.19218870 |
| 149 | CDC42BPA | 0.18427839 |
| 150 | WNK4 | 0.17763013 |
| 151 | PIM2 | 0.16840502 |
| 152 | BLK | 0.13853076 |
| 153 | CAMKK2 | 0.13806748 |
| 154 | ROCK1 | 0.13625409 |
| 155 | EGFR | 0.12925756 |
| 156 | ROCK2 | 0.11518497 |
| 157 | PRKCH | 0.11381524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.92860965 |
| 2 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.68222034 |
| 3 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.45937080 |
| 4 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.18639265 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07701582 |
| 6 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.80998026 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.75283283 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.55460212 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55374597 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45795084 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43480580 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41162900 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.34729834 |
| 14 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.25993714 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22718330 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21725486 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.19375346 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.09442593 |
| 19 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 2.04717787 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02700633 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01694262 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.00723643 |
| 23 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.92849942 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.89544443 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87964690 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.87577030 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.79906585 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.71238988 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67399197 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65464465 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63860725 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.58487138 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.55634026 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53892847 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52914666 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45927229 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.43753861 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.35658150 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30876946 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.30423006 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26216304 |
| 42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.25620605 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25505001 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.23189791 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.17082905 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15383086 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07168896 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05778028 |
| 49 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03721410 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01438444 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 0.99252989 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97058475 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.96462748 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87808907 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87428416 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83725272 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79426435 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78581047 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77667003 |
| 60 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70925863 |
| 61 | Salivary secretion_Homo sapiens_hsa04970 | 0.70060064 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69464633 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65206490 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64559072 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63802802 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62463511 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.61703936 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61067307 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58549559 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58363163 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.56294371 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54760992 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44045052 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43927005 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42502915 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41723609 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40669523 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40249669 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.39888135 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39569712 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.36849438 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36708919 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35560914 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32807176 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32453148 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32256065 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30959752 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.30231610 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.29546759 |
| 90 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.29346459 |
| 91 | Adherens junction_Homo sapiens_hsa04520 | 0.27850983 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26708435 |
| 93 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.26482893 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.24730108 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23953626 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23820924 |
| 97 | Asthma_Homo sapiens_hsa05310 | 0.22311010 |
| 98 | Allograft rejection_Homo sapiens_hsa05330 | 0.21853676 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.20419224 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.19938743 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19605713 |
| 102 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.19277198 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.19236409 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18982560 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.18710153 |
| 106 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.18046473 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17666701 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17630589 |
| 109 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.17373046 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.15790433 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.15580466 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.15031508 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13648107 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.13455347 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12562805 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.12340084 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.11557806 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.10172580 |
| 119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.09590335 |
| 120 | Nicotine addiction_Homo sapiens_hsa05033 | 0.09587522 |
| 121 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.09105804 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.09023722 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08395542 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08011751 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07812973 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.07666963 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07473670 |
| 128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.07371472 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07252399 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.07099441 |
| 131 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.06988501 |
| 132 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.05989867 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05727772 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05649077 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.05457735 |
| 136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.05088928 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.04922041 |
| 138 | Tight junction_Homo sapiens_hsa04530 | 0.04725101 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02044623 |
| 140 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.01839433 |
| 141 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.01748909 |
| 142 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0779139 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | -0.0763974 |
| 144 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | -0.0688085 |
| 145 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0648467 |
| 146 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0474740 |
| 147 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0389768 |
| 148 | Pertussis_Homo sapiens_hsa05133 | -0.0380460 |
| 149 | Mineral absorption_Homo sapiens_hsa04978 | -0.0368498 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | -0.0067916 |
| 151 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0039782 |
| 152 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0001064 |

